The Universite de Montreal evaluated the short-term effectiveness and tolerability of two depression treatments in patients with coronary artery disease (CAD); citalopram, a selective serotonin reuptake inhibitor (SSRI)
“Relamine can help reduce the swelling in the joints, control joint pain associated with osteoarthritis, reduce the onset and progression of osteoarthritis and can be used in combination
In September 2005, Innogenetics sued Abbott alleging the company was infringing its patent which covers a method of genotyping the hepatitis C virus. The jury's decision supported Innogenetics'
High-risk patients who develop invasive fungal infections (IFIs) have a mortality rate ranging from 50-90%. In both these studies Noxafil, also known as posaconazole, was significantly more effective
Pfizer lost patient protection on Zoloft last year. Zoloft is a drug designed to treat patients with depression and anxiety. Teva filed the complaints in the US District
<p>Barr filed an abbreviated new drug application for a generic version of Thalomid 200mg capsules with the FDA in September 2006, claiming that the patents protecting Thalomid from
British Scientists will develop robotics to automate important stem cell research, meaning thousands of experiments will be able to be conducted at once, rather than just a handful
The study shows that the combination of INGN 241 and Avastin is very effective and blocks tumor angiogenesis, the formation of new blood vessels within a tumor that
The Vitamin Shoppe said that the removal of the products followed allegations that the multivitamin contained trace quantities of lead in excess of California labeling requirements. Tom Tolworthy,
Onalta is a radiolabeled peptide that the company intends to develop for the treatment of metastatic pancreatic neuroendocrine and carcinoid tumors in patients whose symptoms are not controlled
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.